SCD Depo​

Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females with Sickle Cell Disease

​

The Women's Health Clinical Research Center at Penn Medicine is conducting a paid research study to see if women with sickle cell disease (SCD) experience any pain differences while using the birth control injection known as Depo, as compared to when not using it. Depo-Provera is already FDA-approved, safe to use, and lasts for 3 months.

​

The study duration is 6 months, with 4-5 in-person visits that include a urine pregnancy test, blood draw, and surveys. Participants will also complete weekly surveys asking about pain and their menstrual cycle, and will be compensated up to $715 for completing all parts of the study. In-person visits will be conducted at 3737 Market Street, Philadelphia, PA.

​

We are seeking women who are between the ages of 18 and 50 who have been diagnosed with SCD, have a regular menstrual cycle, and experience at least one vaso-occlusive pain episode per month.

If this is something you may be interested in learning more about, please click here to fill out a survey or contact us at (267) 785 - 8044.

​

Principal Investigator:
Andrea Roe, MD, MPH
 

Study Coordinator:
Victoria Adeola

victoria.adeola@pennmedicine.upenn.edu

(267) 785 - 8044

​